2021 revised algorithm for the management of knee osteoarthritis—the Chinese viewpoint

被引：0
作者：
Zhiyi Zhang
Cibo Huang
Yongping Cao
Rong Mu
Mun Chan Zhang
Dan Xing
Dongwei Fan
Yunpong Ding
Junhuan Guo
Yong Hou
Lin Jianhao
Nicola Veronese
Jean-Yves Reginster
Olivier Bruyere
Etienne Cavalier
Huaihuan Zhang
机构：
[1] The First Affiliated Hospital of Harbin Medical University,Department of Rheumatology
[2] Beijing Hospital,Department of Rheumatology
[3] Peking University First Hospital,Department of Orthopedics
[4] Peking University People’s Hospital,Arthritis Clinic and Research Center
[5] Peking University,Department of Orthopedics
[6] Peking University Third Hospital,Department of Orthopedics
[7] The Affiliated Hospital of Academy of Military Medical Sciences,Department of Rheumatology and Clinical Immunology
[8] PLA 307Th Hospital,Department of Internal Medicine and Geriatrics
[9] Peking Union Medical College Hospital,Department of Public Health, Epidemiology and Health Economics
[10] Chinese Academy of Medical Sciences,Department of Clinical Chemistry
[11] Peking Union Medical College,Department of Science and Technology
[12] National Clinical Research Center for Dermatologic and Immunologic Diseases,undefined
[13] Geriatric Unit,undefined
[14] University of Palermo,undefined
[15] WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging,undefined
[16] University of Liège,undefined
[17] CHU Sart Tilman B23,undefined
[18] University of Liège,undefined
[19] CHU de Liège,undefined
[20] China Electric Power Research Institute,undefined
来源：
Aging Clinical and Experimental Research | 2021年 / 33卷
关键词：
Knee osteoartrhitis; Patented crystalline glucosamine sulfate; Symptomatic slow-acting drugs for osteoarthritis; Algorithm; China;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2141 / 2147
页数：6
相关论文
共 214 条
[11]  
Hoy D(2019)Safety of symptomatic slow-acting drugs for osteoarthritis: outcomes of a systematic review and meta-analysis Drugs Aging 36 65-99
[12]  
Clynes MA(2016)A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis—from evidence-based medicine to the real-life setting Semin Arthritis Rheum 45 S3-S11
[13]  
Jameson KA(2019)An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) Semin Arthritis Rheum 49 337-350
[14]  
Edwards MH(2008)GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 924-772
[15]  
Beaudart C(2016)The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis is applicable to Chinese clinical practice: a consensus statement of leading Chinese and ESCEO osteoarthritis experts Chin J Pract Int Med 36 762-652
[16]  
Biver E(2016)The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis is applicable to Russian clinical practice: a consensus statement of leading Russian and ESCEO osteoarthritis experts Hayчнo-пpaктичecкaя peвмaтoлoгия/Rheumatol Sci Pract 54 641-385
[17]  
Bruyère O(2019)Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment Int J Rheum Dis 22 376-1373
[18]  
Bruyere O(2017)International endorsement of the ESCEO algorithm for management of knee osteoarthritis in clinical practice Semin Arthritis Rheum 47 e10-1156
[19]  
Cooper C(2019)East meets West: current practices and policies in the management of musculoskeletal aging Aging Clin Exp Res 31 1351-653
[20]  
Pelletier JP(2021)2019 revised algorithm for the management of knee osteoarthritis: the Southeast Asian viewpoint Aging Clin Exp Res 33 1149-1642
12345678910